Literature DB >> 24941131

Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications.

Titilola S Akingbola1, Bamidele O Tayo, Babatunde Salako, Jennifer E Layden, Lewis L Hsu, Richard S Cooper, Victor R Gordeuk, Santosh L Saraf.   

Abstract

To identify factors that affect manifestations of sickle cell anemia we compared patients 11-30 years of age from University of Ibadan, Ibadan, Oyo, Nigeria (n = 214) and University of Illinois at Chicago, Chicago, IL, USA (n = 209). Paralleling findings in the general populations of the two countries, the Chicago patients were more often overweight or obese as defined by the Centers for Disease Control and Prevention (Atlanta, GA, USA) guidelines, and more often had elevated blood pressure (BP) as defined by the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD, USA guidelines. The Ibadan patients did not receive the pneumococcal vaccine or hydroxyurea (HU) therapy as frequently as the Chicago patients. Consistent with lower rates of elevated BP and increased body mass index (BMI), stroke history was less frequent in the Ibadan patients ≥18 years old. Furthermore, in combined analyses, systolic and diastolic BP directly correlated with BMI, and elevated weight status independently associated with history of stroke. Our findings are consistent with the possibility that higher values for BMI and BP in Chicago sickle cell anemia patients may contribute to an increased risk of stroke and highlights the need for measures to reduce these risk factors. On the other hand, lower pneumococcal vaccination and HU therapy rates in Ibadan patients highlights the need for more improved vaccination coverage and for studies to define the role of HU therapy in Africa.

Entities:  

Keywords:  Hydroxyurea (HU); hypertension; pneumococcal vaccination; sickle cell anemia; weight

Mesh:

Year:  2014        PMID: 24941131      PMCID: PMC4161131          DOI: 10.3109/03630269.2014.927363

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  31 in total

1.  Foetal haemoglobin in Nigerian children with sickle cell anaemia. Effect on haematological parameters and clinical severity.

Authors:  O J Fatunde; A B Scott-Emuakpor
Journal:  Trop Geogr Med       Date:  1992-07

2.  Arterial blood pressure in adult Nigerians with sickle cell anemia.

Authors:  N I Oguanobi; B J C Onwubere; O G Ibegbulam; S O Ike; B C Anisiuba; E C Ejim; O Agwu
Journal:  J Cardiol       Date:  2010-08-19       Impact factor: 3.159

3.  Current sickle cell disease management practices in Nigeria.

Authors:  N Galadanci; B J Wudil; T M Balogun; G O Ogunrinde; A Akinsulie; F Hasan-Hanga; A S Mohammed; M O Kehinde; J A Olaniyi; I N Diaku-Akinwumi; B J Brown; S Adeleke; O E Nnodu; I Emodi; S Ahmed; A O Osegbue; N Akinola; H I O Opara; S A Adegoke; J Aneke; A D Adekile
Journal:  Int Health       Date:  2013-10-10       Impact factor: 2.473

4.  The prevalence of hypertension in seven populations of west African origin.

Authors:  R Cooper; C Rotimi; S Ataman; D McGee; B Osotimehin; S Kadiri; W Muna; S Kingue; H Fraser; T Forrester; F Bennett; R Wilks
Journal:  Am J Public Health       Date:  1997-02       Impact factor: 9.308

5.  Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Authors:  Martin H Steinberg; Franca Barton; Oswaldo Castro; Charles H Pegelow; Samir K Ballas; Abdullah Kutlar; Eugene Orringer; Rita Bellevue; Nancy Olivieri; James Eckman; Mala Varma; Gloria Ramirez; Brian Adler; Wally Smith; Timothy Carlos; Kenneth Ataga; Laura DeCastro; Carolyn Bigelow; Yogen Saunthararajah; Margaret Telfer; Elliott Vichinsky; Susan Claster; Susan Shurin; Kenneth Bridges; Myron Waclawiw; Duane Bonds; Michael Terrin
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

6.  Decades after the cooperative study: a re-examination of systemic blood pressure in sickle cell disease.

Authors:  Payal C Desai; Allison M Deal; Julia E Brittain; Susan Jones; Alan Hinderliter; Kenneth I Ataga
Journal:  Am J Hematol       Date:  2012-06-20       Impact factor: 10.047

7.  Profile of the Nigerian sickle cell anaemia patients above 30 years of age.

Authors:  A Yetunde; C C Anyaegbu
Journal:  Cent Afr J Med       Date:  2001-04

8.  The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Authors:  Martin H Steinberg; William F McCarthy; Oswaldo Castro; Samir K Ballas; F Danny Armstrong; Wally Smith; Kenneth Ataga; Paul Swerdlow; Abdullah Kutlar; Laura DeCastro; Myron A Waclawiw
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

9.  Cardiorenal risk prevalence in sickle cell hemoglobinopathy.

Authors:  H Abo-Zenah; M Moharram; A M El Nahas
Journal:  Nephron Clin Pract       Date:  2009-04-23

10.  Male gender, increased blood viscosity, body mass index and triglyceride levels are independently associated with systemic relative hypertension in sickle cell anemia.

Authors:  Yann Lamarre; Marie-Laure Lalanne-Mistrih; Marc Romana; Nathalie Lemonne; Daniele Mougenel; Xavier Waltz; Benoît Tressières; Maryse Etienne-Julan; Vanessa Tarer; Marie-Dominique Hardy-Dessources; Philippe Connes
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more
  12 in total

1.  Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.

Authors:  Jifang Zhou; Jin Han; Edith A Nutescu; William L Galanter; Surrey M Walton; Victor R Gordeuk; Santosh L Saraf; Gregory S Calip
Journal:  Br J Haematol       Date:  2019-02-03       Impact factor: 6.998

2.  Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.

Authors:  Chung-Jen Chen; Sabrina Bakeera-Kitaka; Ezekiel Mupere; Philip Kasirye; Deogratias Munube; Richard Idro; Heather Hume; Betsy Pfeffer; Philip LaRussa; Nancy S Green
Journal:  J Paediatr Child Health       Date:  2018-11-09       Impact factor: 1.954

3.  Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.

Authors:  Abel Makubi; Bruno P Mmbando; Enrico M Novelli; Johnson Lwakatare; Deogratius Soka; Harvest Marik; Kemi Tibarazwa; Mariam Ngaeje; Charles R Newton; Mark T Gladwin; Julie Makani
Journal:  Br J Haematol       Date:  2016-09-21       Impact factor: 6.998

Review 4.  Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.

Authors:  Amy Geard; Gift D Pule; David Chelo; Valentina Josiane Ngo Bitoungui; Ambroise Wonkam
Journal:  OMICS       Date:  2016-10

5.  Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana.

Authors:  Amma Benneh-Akwasi Kuma; Amma Twumwa Owusu-Ansah; Mary Akua Ampomah; Fredericka Sey; Edeghonghon Olayemi; Mehdi Nouraie; Solomon Fiifi Ofori-Acquah
Journal:  PLoS One       Date:  2018-01-04       Impact factor: 3.240

6.  Nutritional perspectives on sickle cell disease in Africa: a systematic review.

Authors:  Eunice Berko Nartey; Jonathan Spector; Seth Adu-Afarwuah; Catherine L Jones; Alan Jackson; Agartha Ohemeng; Rajiv Shah; Alice Koryo-Dabrah; Amma Benneh-Akwasi Kuma; Hyacinth I Hyacinth; Matilda Steiner-Asiedu
Journal:  BMC Nutr       Date:  2021-03-18

7.  An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research.

Authors:  Andrew D Campbell; Raffaella Colombatti; Biree Andemariam; Crawford Strunk; Immacolata Tartaglione; Connie M Piccone; Deepa Manwani; Eugenia Vicky Asare; Donna Boruchov; Fatimah Farooq; Rebekah Urbonya; Gifty Dankwah Boatemaa; Silverio Perrotta; Laura Sainati; Angela Rivers; Sudha Rao; William Zempsky; Fredericka Sey; Catherine Segbefia; Baba Inusa; Charles Antwi-Boasiako
Journal:  J Racial Ethn Health Disparities       Date:  2020-05-16

8.  Vitamin D levels are low in adult patients with sickle cell disease in Jamaica and West Africa.

Authors:  Bamidele O Tayo; Titilola S Akingbola; Babatunde L Salako; Colin A McKenzie; Marvin Reid; Jennifer Layden; Ifeyinwa Osunkwo; Jacob Plange-Rhule; Amy Luke; Ramon Durazo-Arvizu; Richard S Cooper
Journal:  BMC Hematol       Date:  2014-08-16

Review 9.  Neurologic complications of sickle cell disease in Africa: A systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Michel K Mengnjo; Nicolas Nicastro; Joseph Kamtchum-Tatuene
Journal:  Neurology       Date:  2017-09-01       Impact factor: 9.910

10.  Prescription audit in a paediatric sickle cell clinic in South-West Nigeria: A cross-sectional retrospective study.

Authors:  Fadare Joseph Olusesan; Olatunya Oladele Simeon; Ogundare Ezra Olatunde; Oluwayemi Isaac Oludare; Agaja Oyinkansola Tolulope
Journal:  Malawi Med J       Date:  2017-12       Impact factor: 0.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.